Study Group: Allergists (New York)
Council Members in this Study Group: 36
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Mitchell Boxer
Assistant Clinical Professor
Albert Einstein College of Medicine
Mitchell Boxer, MD, is Director of the Adult Allergy Section at Long Island Jewish Medical Center and Assistant Clinical Professor at Albert Einstein Medical College. He also runs his own private practice. Dr. Boxer completed his fellowship at Northwestern...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
August 30, 2007
Analysis by: Mitchell Boxer, Assistant Clinical Professor,Collegium Pharmaceutical provides update on development of its nasal inhaled steroid for allergic rhinitis | www.pipelinereview.com
A new nasal corticosteroid being released by another pharmaceutical company
-
August 30, 2007
Analysis by: Mitchell Boxer, Assistant Clinical Professor,New antihistamine gets FDA green light.(RX CARE)(Levocetirizine (Xyzal) by UCB Inc. and Sanofi-Aventis ) | www.therapeuticsdaily.com
Zyrtec will soon be available over the counter and this new product will attempt to keep the antihistamine market share for Sanofi-Aventis - although Zyrtec is presently manufactured by Pfizer. The antihistamine market is quite large and the OTC versus prescription situation is making this problematic for both physicians, patients and insurance companies.
-
intranasal antibiotics for chronic sinusitis
April 23, 2007
Analysis by: Mitchell Boxer, Assistant Clinical Professor,FDA Approves Fast Track Designation for Naryx Pharma’s Product for Chronic Sinusitis | www.naryxpharma.com
I have not found nebulized antibiotic therapy to be of great success in patients with chronic sinusitis. There are already a few pharmacies that have formulated an array of nebulized antibiotics and I have tried them in a few patients with no success.
-
February 27, 2007
Analysis by: Mitchell Boxer, Assistant Clinical Professor,FDA Orders Black Box Anaphylaxis Warning for Omalizumab (Xolair) | www.medpagetoday.com
There is a concern about anaphylaxis secondary to Xolair administration and this may result in longer waiting times after the administration of the drug.
-
February 13, 2007
Analysis by: Mitchell Boxer, Assistant Clinical Professor,Patient Treatment Completed in Phase 3 Trial of C1-Esterase Inhibitor in Hereditary Angioedema | www.ptcommunity.com
HAE is a rare but potentially life threatening immunologic disease. If c1 esterase inhibitor is found to be effective in preventing exacerbations of HAE than this novel treatment will have a great impact on the lives of those affected and will undoubtedly replace the present treatments such as androgens in preventing attacks. It would be of interest in seeing how the European community is presently using this replacement therapy.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Owner
- Physician - Division Head
- Director
- Physician - Director
- Medical Director
- Physician - Department Chair
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Allergists (US) | 419 |
| Pulmonologists (US) | 759 |
| Immunologists (US) | 384 |
| Physicians who Treat Asthma (US) | 610 |
| Physicians in the U.S. who Treat Chronic Obstructive Pulmonary Disease (COPD) | 375 |
| Pediatricians (US) | 1695 |
| Pediatric Allergist Physicians in the U.S. | 137 |
| Pediatric Allergy Physicians | 183 |